Lisa A. Spencer

2.1k citations
29 papers · 1.5k indexed · h-index 17
Topics
Eosinophilic Disorders and Syndromes (16 papers)Eosinophilic Esophagitis (9 papers)IL-33, ST2, and ILC Pathways (8 papers)

In The Last Decade

Lisa A. Spencer

28 papers receiving 1.4k citations

Peers

Lisa A. Spencer
Comparison fields: 5 of 96
  • Immunology 708
  • Physiology 585
  • Surgery 402
  • Rheumatology 394
  • Pulmonary and Respiratory Medicine 218
Replace K M Leiferman with:
K M Leiferman United States
Avery W. Brewer United States
Raffaella Ghittoni Italy
R Châtelain Germany
Louise Hartson United States
Betsy C. Taylor United States
Sergio Arce United States
Simone A. Nish United States
Y Hitoshi Japan
D T McKenzie United States
Lisa A. Spencer relative to K M Leiferman United States K M Leiferman's profile →
Citations per field
00.5×10×14×
K M Leiferman · 1×
Citations per year

Countries citing papers authored by Lisa A. Spencer

Since Specialization
Citations

This map shows the geographic impact of Lisa A. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. Spencer more than expected).

Fields of papers citing papers by Lisa A. Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa A. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. Spencer. The network helps show where Lisa A. Spencer may publish in the future.

Co-authorship network of co-authors of Lisa A. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa A. Spencer. A scholar is included among the top collaborators of Lisa A. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa A. Spencer. Lisa A. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 6
4 4
5 15
6 10
7 23
8 329
9 81
10 38
11 29
12 60
13 41
14 8
15 70
16 20
17 2
18 7
19 21
20 1

About Lisa A. Spencer

Lisa A. Spencer is a scholar working on Rheumatology, Immunology and Virology, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Eosinophilic Disorders and Syndromes (16 papers), Eosinophilic Esophagitis (9 papers) and IL-33, ST2, and ILC Pathways (8 papers). The work is most often cited by research in Immunology (708 citations), Immunology and Allergy (168 citations) and Rheumatology (394 citations). Lisa A. Spencer has collaborated with scholars based in United States, Brazil and Australia. Frequent co-authors include Peter F. Weller, Rossana C. N. Melo, Ann M. Dvořàk, Shigeharu Ueki, Ionita Ghiran, Roger Lord, Graham L. Jones, Allan Saul, Kohei Honda and Makoto Hirokawa. Their work appears in journals such as Blood, Nature reviews. Immunology and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026